Clinical Trial Update: Topical Vancomycin in Prevention of Methicillin-Resistant Staphylococcal Related Mediastinitis in Patients Receiving Coronary Artery Bypass Graft [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of topical vancomycin to prevent methicillin-resistant Staphylococcus aureus–related mediastinitis in patients unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Topical Vancomycin (vancomycin)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Coronary Artery Disease | NA | Status: COMPLETED